MarketCap
Facebook
X
TelegramAnnual report 2022
added 03-30-2023
HTG Molecular Diagnostics ROCE Ratio 2011-2026 | HTGM
Annual ROCE Ratio HTG Molecular Diagnostics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -219.45 | -171.39 | -70.04 | -52.35 | -43.97 | -223.93 | -288.52 | -57.02 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -43.97 | -288.52 | -140.83 |
Quarterly ROCE Ratio HTG Molecular Diagnostics
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -142.22 | -158.25 | -110.42 | -76.93 | -45.74 | -63.58 | -65.39 | -86.37 | -89.58 | -108.86 | -110.3 | -87.7 | -53.39 | -76.17 | -79.67 | -87.01 | -66.82 | 99.95 | 289.49 | 488.8 | 524.28 | 632.61 | 574.17 | 507.87 | 341.26 | 312.7 | 175.81 | 34.1 | -80.19 | -75.69 | -42.62 | -9.53 | 13.58 | 13.58 | 9.08 | 3.95 | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 632.61 | -158.25 | 64.02 |
ROCE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-89.9 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
25.0 | $ 117.17 | 1.83 % | $ 35.6 B |  USA |
 |
Interpace Biosciences
IDXG
|
18.26 | $ 2.2 | -4.35 % | $ 9.73 M | USA |
 |
Aspira Women's Health
AWH
|
114.15 | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
-360.98 | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
-132.81 | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
1809.55 | - | - | $ 9.42 M |  Israel |
 |
DermTech
DMTK
|
-181.44 | - | -11.32 % | $ 2.94 M | USA |
 |
CareDx, Inc
CDNA
|
-10.16 | $ 16.67 | 3.86 % | $ 888 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-2.26 | - | - | $ 562 M |  Britain |
 |
Myriad Genetics
MYGN
|
-105.22 | $ 4.6 | 5.63 % | $ 426 M | USA |
|
Akumin
AKU
|
58.25 | - | -17.87 % | $ 25.9 M |  Canada |
 |
NeoGenomics
NEO
|
-9.11 | $ 7.96 | 3.51 % | $ 1.02 B | USA |
 |
Enzo Biochem
ENZ
|
-22.04 | - | -8.98 % | $ 14.8 K | USA |
 |
Co-Diagnostics
CODX
|
-236.6 | $ 1.43 | 4.38 % | $ 1.9 M | USA |
 |
Exact Sciences Corporation
EXAS
|
-8.59 | - | - | $ 19.8 B | USA |
 |
Accelerate Diagnostics
AXDX
|
62.7 | - | -61.36 % | $ 2.46 M | USA |
 |
Castle Biosciences
CSTL
|
1.9 | $ 23.38 | 1.08 % | $ 649 M | USA |
 |
Global Cord Blood Corporation
CO
|
12.48 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
-18.87 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-347.69 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-15.41 | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
0.8 | $ 177.66 | 1.14 % | $ 8.81 B | USA |
 |
Senseonics Holdings
SENS
|
-111.94 | $ 6.69 | 0.15 % | $ 279 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
9.75 | - | - | $ 10.7 B | USA |
 |
Medpace Holdings
MEDP
|
116.53 | $ 497.88 | 0.88 % | $ 14.4 B | USA |
 |
Danaher Corporation
DHR
|
8.93 | $ 194.98 | 2.83 % | $ 139 B | USA |
 |
Neuronetics
STIM
|
-140.48 | $ 1.37 | 1.11 % | $ 90.4 M | USA |
 |
Heska Corporation
HSKA
|
-4.81 | - | - | $ 1.31 B | USA |
 |
Illumina
ILMN
|
-35.1 | $ 125.77 | 4.0 % | $ 20 B | USA |
 |
Thermo Fisher Scientific
TMO
|
14.5 | $ 511.92 | 3.14 % | $ 193 B | USA |
 |
Fulgent Genetics
FLGT
|
-6.52 | $ 15.3 | 5.99 % | $ 463 M | USA |
 |
Trinity Biotech plc
TRIB
|
0.08 | $ 0.71 | -0.74 % | $ 61.9 M |  Irlanda |
 |
Guardant Health
GH
|
440.3 | $ 81.33 | 3.47 % | $ 10.2 B | USA |
 |
QIAGEN N.V.
QGEN
|
8.07 | - | - | $ 10.6 B |  Niderland |
 |
Anixa Biosciences
ANIX
|
-77.18 | $ 2.79 | 3.72 % | $ 90.5 K | USA |
 |
Twist Bioscience Corporation
TWST
|
-28.81 | $ 50.08 | 4.52 % | $ 3 B | USA |
 |
Biomerica
BMRA
|
-125.14 | $ 2.09 | -1.88 % | $ 4.8 M | USA |
 |
Invitae Corporation
NVTA
|
-93.18 | - | - | $ 21.2 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
6.33 | $ 28.56 | 0.88 % | $ 20 B | Niderland |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 110.47 | 3.43 % | $ 9.11 B | Irlanda |
 |
Soleno Therapeutics
SLNO
|
2.09 | $ 52.66 | 0.05 % | $ 2.68 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
16.06 | $ 264.01 | 1.18 % | $ 22 B | USA |
 |
Natera
NTRA
|
-76.66 | $ 201.61 | 4.44 % | $ 19.8 B | USA |
 |
Celcuity
CELC
|
-171.24 | $ 119.02 | 1.6 % | $ 5.57 B | USA |
 |
Lantheus Holdings
LNTH
|
28.52 | $ 81.19 | 0.74 % | $ 5.48 B | USA |
 |
Motus GI Holdings
MOTS
|
-443.13 | - | -34.28 % | $ 263 K | Israel |
 |
Waters Corporation
WAT
|
7.05 | $ 322.55 | 0.75 % | $ 19.2 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
21.7 | $ 191.19 | -0.17 % | $ 21.2 B | USA |